D. Guyonnet

发表

Dietary patterns, digestive symptoms, and health-related quality of life in women reporting minor digestive symptoms.

K. Whelan, B. Holmes, Fatiha Habi-Rachedi, 2017, Nutrition.

Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic.

D. Guyonnet, C. Belloir, M. Suschetet, 2002, Carcinogenesis.

High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial

D. Guyonnet, S. Lemieux, Stéphanie Dudonné, 2021, BMC Urology.

Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink.

A. Drewnowski, A. Lluch, D. Guyonnet, 2006, Journal of the American Dietetic Association.

Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function

D. Guyonnet, A. Rawlings, T. Lassel, 2008, Experimental dermatology.

Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction.

D. Guyonnet, C. Belloir, M. Suschetet, 2001, Mutation research.

Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues.

D. Guyonnet, M. Suschetet, M. Siess, 1999, Toxicology and applied pharmacology.

Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation.

D. Guyonnet, C. Belloir, M. Suschetet, 2000, Mutation research.

Post-initiation modulating effects of allyl sulfides in rat hepatocarcinogenesis.

D. Guyonnet, R. Bergès, M. Chagnon, 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Method for Rapid Purification of Class IIa Bacteriocins and Comparison of Their Activities

D. Guyonnet, C. Fremaux, J. Berjeaud, 2000, Applied and Environmental Microbiology.

A Combined Nutrient and Lactulose Challenge Test Allows Symptom-Based Clustering of Patients With Irritable Bowel Syndrome

B. Naliboff, E. Mayer, D. Guyonnet, 2013, The American Journal of Gastroenterology.

Changes of the human gut microbiome induced by a fermented milk product

S. Kennedy, N. Pons, S. Ehrlich, 2014, Scientific Reports.

Diallyl disulfide (DADS) enhances gap-junctional intercellular communication by both direct and indirect mechanisms in rat liver cells.

D. Guyonnet, C. Chaumontet, A. le Bon, 2003, Carcinogenesis.

Comprehensive analysis of the metabolic and genomic features of tannin-transforming Lactiplantibacillus plantarum strains

D. Guyonnet, Y. Desjardins, Denis Roy, 2022, Scientific Reports.

Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further

D. Guyonnet, D. Roy, Y. Desjardins, 2021, Frontiers in Nutrition.

Consumption of fermented milk product with probiotic modulates brain activity.

B. Naliboff, E. Mayer, Beatrice Trotin, 2013, Gastroenterology.

Shaping the Future of Probiotics and Prebiotics.

D. Guyonnet, D. van Sinderen, G. Gibson, 2021, Trends in microbiology.

Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial

O. Chassany, P. Ducrotte, D. Guyonnet, 2007, Alimentary pharmacology & therapeutics.

Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase

D. Guyonnet, P. Clouet, J. Demarquoy, 2004, Molecular and Cellular Biochemistry.

Effect of a low‐flatulogenic diet in patients with flatulence and functional digestive symptoms

F. Guarner, J. Malagelada, F. Azpiroz, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet

C. Manichanh, F. Guarner, J. Clemente, 2013, Gut.

Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome.

J. Tap, D. Guyonnet, H. Törnblom, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

P. Whorwell, L. Houghton, D. Guyonnet, 2009, Alimentary pharmacology & therapeutics.

Cellular Antioxidant Effect of an Aronia Extract and Its Polyphenolic Fractions Enriched in Proanthocyanidins, Phenolic Acids, and Anthocyanins

D. Guyonnet, Y. Desjardins, Jose A. Villa-Rodriguez, 2022, Antioxidants.

Fermented milk containing Bifidobacterium lactis DN‐173 010 improved self‐reported digestive comfort amongst a general population of adults. A randomized, open‐label, controlled, pilot study

D. Guyonnet, A. Woodcock, C. Hall, 2009, Journal of digestive diseases.

Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study

O. Chassany, D. Guyonnet, L. Mhamdi, 2009, British Journal of Nutrition.

Brain Structure and Response to Emotional Stimuli as Related to Gut Microbial Profiles in Healthy Women

Jennifer S. Labus, Emeran A. Mayer, Kirsten Tillisch, 2017, Psychosomatic medicine.

A randomized, double‐blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I‐2494 in healthy women reporting minor digestive symptoms

D. Guyonnet, P. Marteau, P. Lafaye De Micheaux, 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA©) questionnaire: development and psychometric validation

O. Chassany, D. Guyonnet, C. Picard, 2008, Public Health Nutrition.

The Intestinal Gas Questionnaire: development of a new instrument for measuring gas‐related symptoms and their impact on daily life

O. Chassany, M. Duracinsky, F. Azpiroz, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome

J. Tap, D. Guyonnet, S. Störsrud, 2019, PloS one.

Consumption of a Fermented Milk Product Containing Bifidobacterium lactis CNCM I-2494 in Women Complaining of Minor Digestive Symptoms: Rapid Response Which Is Independent of Dietary Fibre Intake or Physical Activity

P. Whorwell, D. Guyonnet, B. Le Nevé, 2019, Nutrients.

Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome

F. Guarner, F. Azpiroz, D. Guyonnet, 2015, Journal of clinical gastroenterology.

Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure.

O. Chassany, B. Naliboff, E. Mayer, 2013, The British journal of nutrition.

It's all in the mix: diagnosis and management of food intolerance reply

J. Tap, L. Öhman, D. Guyonnet, 2016 .

Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome

J. Tap, D. Guyonnet, S. Störsrud, 2019, PloS one.

589 Modulation of the Brain-Gut Axis After 4-Week Intervention With a Probiotic Fermented Dairy Product

B. Naliboff, E. Mayer, Beatrice Trotin, 2012 .